These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 7538529

  • 21. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest.
    Santos-Argumedo L, Gordon J, Heath AW, Howard M.
    Cell Immunol; 1994 Jul; 156(2):272-85. PubMed ID: 7517793
    [Abstract] [Full Text] [Related]

  • 22. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
    Kelly K, Knox KA.
    Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
    [Abstract] [Full Text] [Related]

  • 23. Changes in CD44 expression during B cell differentiation in the human tonsil.
    Kremmidiotis G, Zola H.
    Cell Immunol; 1995 Apr 01; 161(2):147-57. PubMed ID: 7535194
    [Abstract] [Full Text] [Related]

  • 24. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
    Defrance T, Vanbervliet B, Durand I, Briolay J, Banchereau J.
    Eur J Immunol; 1992 Nov 01; 22(11):2831-9. PubMed ID: 1385152
    [Abstract] [Full Text] [Related]

  • 25. Activated CD4+ T cells induce CD40-dependent proliferation of human B cell precursors.
    Renard N, Duvert V, Blanchard D, Banchereau J, Saeland S.
    J Immunol; 1994 Feb 15; 152(4):1693-701. PubMed ID: 7509827
    [Abstract] [Full Text] [Related]

  • 26. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype.
    Galibert L, Burdin N, de Saint-Vis B, Garrone P, Van Kooten C, Banchereau J, Rousset F.
    J Exp Med; 1996 Jan 01; 183(1):77-85. PubMed ID: 8551247
    [Abstract] [Full Text] [Related]

  • 27. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E, Malecka A, Myklebust JH, Tierens A, Aasheim HC, Nesland JM, Smeland E, Kvaløy S, Delabie J.
    J Pathol; 2005 Jul 01; 206(3):312-9. PubMed ID: 15892171
    [Abstract] [Full Text] [Related]

  • 28. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
    Kansas GS, Tedder TF.
    J Immunol; 1991 Dec 15; 147(12):4094-102. PubMed ID: 1721639
    [Abstract] [Full Text] [Related]

  • 29. Spontaneous production of granulocyte colony-stimulating factor in vitro by human B-lineage lymphocytes is a distinctive marker of germinal center cells.
    Corcione A, Baldi L, Zupo S, Dono M, Rinaldi GB, Roncella S, Taborelli G, Truini M, Ferrarini M, Pistoia V.
    J Immunol; 1994 Oct 01; 153(7):2868-77. PubMed ID: 7522243
    [Abstract] [Full Text] [Related]

  • 30. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor.
    Wheeler K, Pound JD, Gordon J, Jefferis R.
    Eur J Immunol; 1993 May 01; 23(5):1165-8. PubMed ID: 7682959
    [Abstract] [Full Text] [Related]

  • 31. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood.
    Miyawaki T, Uehara T, Nibu R, Tsuji T, Yachie A, Yonehara S, Taniguchi N.
    J Immunol; 1992 Dec 01; 149(11):3753-8. PubMed ID: 1385530
    [Abstract] [Full Text] [Related]

  • 32. Subepithelial B cells in the human palatine tonsil. II. Functional characterization.
    Dono M, Zupo S, Augliera A, Burgio VL, Massara R, Melagrana A, Costa M, Grossi CE, Chiorazzi N, Ferrarini M.
    Eur J Immunol; 1996 Sep 01; 26(9):2043-9. PubMed ID: 8814244
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.
    Burdin N, Van Kooten C, Galibert L, Abrams JS, Wijdenes J, Banchereau J, Rousset F.
    J Immunol; 1995 Mar 15; 154(6):2533-44. PubMed ID: 7533177
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
    Choi MS, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GG.
    Eur J Immunol; 1995 May 15; 25(5):1352-7. PubMed ID: 7539757
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
    Daniel PT, Krammer PH.
    J Immunol; 1994 Jun 15; 152(12):5624-32. PubMed ID: 7515909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.